Endoscopic endonasal approach for growth hormone secreting pituitary adenomas: outcomes in 53 patients using 2010 consensus criteria for remission. - Wikidata - awgldk - TriplyDB

Endoscopic endonasal approach for growth hormone secreting pituitary adenomas: outcomes in 53 patients using 2010 consensus criteria for remission.

Endoscopic endonasal approach for growth hormone secreting pituitary adenomas: outcomes in 53 patients using 2010 consensus criteria for remission.

http://www.wikidata.org/entity/Q38062441

about

Advancing Treatment of Pituitary Adenomas through Targeted Molecular Therapies: The Acromegaly and Cushing Disease Paradigms Surgical treatment of acromegaly according to the 2010 remission criteria: systematic review and meta-analysis.An analysis of granulation patterns, MIB-1 proliferation indices and p53 expression in 101 patients with acromegaly.Surgery induced hypopituitarism in acromegalic patients: a systematic review and meta-analysis of the results.A two-year audit of outcomes of pituitary surgery at an Australian teaching hospital.The surgical treatment of acromegaly.Transsphenoidal surgery for acromegaly: predicting remission with early postoperative growth hormone assays.Long-Term Endocrine Outcomes Following Endoscopic Endonasal Transsphenoidal Surgery for Acromegaly and Associated Prognostic Factors.Microsurgical therapy of pituitary adenomas.How to deal with giant pituitary adenomas: transsphenoidal or transcranial, simultaneous or two-staged?The posterior nasoseptal flap: A novel technique for closure after endoscopic transsphenoidal resection of pituitary adenomas.

P2860

Q26741707-F24828C1-8307-485A-AD4F-83EF919DF41F Q36120577-D59D78D6-1893-4DF9-BACF-99CA362B9E57 Q38252677-C5D599F9-1436-49D1-BAC0-C7C7495CB1F0 Q38538268-A8B55C21-8C58-4531-866F-04E4A8B56F5F Q38694477-F4284EDD-F33A-4318-985E-57BFF2F9FA4A Q38988047-63C619DE-A7C1-4999-B1AB-70057A6CDDA0 Q42458153-949BEEF4-E94C-4B2A-B861-B6290D5A571F Q42507980-14272262-6DF3-40F2-926A-A2A75EC7F8C2 Q47234681-2635CB35-F3B2-4D12-A9D4-5748446421FE Q48874144-A9762B99-CEAB-4ADD-80E3-B08C0D53BD46 Q52661627-DBE17A32-87F7-441F-8B97-99DCB5C8C6E4

P2860

Endoscopic endonasal approach for growth hormone secreting pituitary adenomas: outcomes in 53 patients using 2010 consensus criteria for remission.

http://www.wikidata.org/entity/Q38062441

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Endoscopic endonasal approach ...... sensus criteria for remission.

@en

type

label

Endoscopic endonasal approach ...... sensus criteria for remission.

@en

prefLabel

Endoscopic endonasal approach ...... sensus criteria for remission.

@en

P1433

Q38062441-DC4176F0-46FE-41EC-8F4C-1DCC1F669983

P1476

Q38062441-4C6A0CA7-101D-4A9B-B09D-08CF0D4949D7

P2093

Q38062441-1B1D5131-A685-463D-999F-1F51EDCA3718

Q38062441-4CB622B6-4E08-4EB0-B379-205ECE203DFC

Q38062441-513425E3-072F-4CE1-A3C3-AD791C5BFF5B

Q38062441-56FDC1B7-5E17-4D77-A3B7-723C9F5180A9

Q38062441-696ADE68-604D-4A93-9073-7D3D5A3C75A9

Q38062441-791F2594-D43C-44DF-9220-602EEF041C2B

Q38062441-81EFEF4A-3DFF-42F5-B865-E5C4E58688A3

Q38062441-85D59792-90C5-411C-AAC1-75EDB404262E

Q38062441-B5387277-2C8C-4AD3-9175-B40C975263FF

Q38062441-F94D1D56-05DD-439E-B09B-661450E7E256

P2860

Q38062441-025D2595-D9B1-47DA-B766-C425929A8FB0

Q38062441-059E5F6D-D616-443F-9BEE-951907E74BC0

Q38062441-062BF431-F840-49EF-A2AF-A7C0FC1E23E5

Q38062441-20C62045-4396-4579-85AD-72B162BCD9F5

Q38062441-276EC766-B7E6-4CE1-BA74-2BCF3D7D8D9C

Q38062441-3BCCDE74-BC17-41CC-8744-107641B9B5A3

Q38062441-3F7409A0-C62A-4D6E-A4A2-8FAB8D0800F1

Q38062441-3FA52513-D754-4C96-99C9-9B572AFE5A8B

Q38062441-415EFE1A-7BED-4C0F-BA7C-05BD2209A69A

Q38062441-4DE8A99E-45DE-41EB-A060-EAA13B1DE668

P2888

Q38062441-92DCC808-0483-477F-A259-2C3340DB7145

P304

Q38062441-68B5DF96-6E48-4C24-95AD-196EC2B61852

P31

Q38062441-081FA04D-9433-49AA-A123-255000E89732

P356

Q38062441-9D6D32C6-FB4A-44AB-8184-3F34EDCDE34A

P433

Q38062441-13BA8FB9-5357-4BAE-B64A-0E621767E741

P478

Q38062441-A6381776-C91B-482E-983A-01A8D1D0C5F1

P577

Q38062441-55E765C5-5FDB-442A-BE1E-64EAE3E7CA8D

P5875

Q38062441-83EFF335-2FEE-4F18-AB54-C064646524D5

P698

Q38062441-E0A00E38-B432-4723-A94C-E7E3DC90905F

P356

S11102-012-0440-6

P1433

P1476

Endoscopic endonasal approach ...... sensus criteria for remission.

@en

P2093

Alessandro Paluzzi

http://www.w3.org/2001/XMLSchema#string

Carl H Snyderman

http://www.w3.org/2001/XMLSchema#string

Hanady Zainah

http://www.w3.org/2001/XMLSchema#string

Juan C Fernandez-Miranda

http://www.w3.org/2001/XMLSchema#string

Matthew J Tormenti

http://www.w3.org/2001/XMLSchema#string

Paul A Gardner

http://www.w3.org/2001/XMLSchema#string

Samuel S Shin

http://www.w3.org/2001/XMLSchema#string

Sue M Challinor

http://www.w3.org/2001/XMLSchema#string

William E Rothfus

http://www.w3.org/2001/XMLSchema#string

Yue-Fang Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome.

Microscopic versus endoscopic transnasal pituitary surgery.

Endoscopic transnasal transsphenoidal treatment of pathology of the sellar region.

Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings.

Combination treatment with somatostatin analogues and pegvisomant in acromegaly.

Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly.

Medical therapy of acromegaly

Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa.

Clinical review: The antitumoral effects of somatostatin analog therapy in acromegaly.

Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs.

P2888

s11102-012-0440-6

P304

435-444

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11102-012-0440-6

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233769949

http://www.w3.org/2001/XMLSchema#string

P698

23179961

http://www.w3.org/2001/XMLSchema#string